Boston Scientific introduces Precision pain reliever
This article was originally published in The Gray Sheet
Spinal cord stimulation system for the treatment of chronic pain in the limbs, trunk and back will undergo a full European launch in 2006, with initial roll-out to begin this year. The firm received a CE mark for the device Sept. 13. Boston Scientific acquired the PMA-approved device with its $740 mil. purchase of Advanced Bionics in June 2004 and launched it in the U.S. in March. The European version includes a longer-life battery - not yet approved in the U.S. - that can last up to 25 years. Boston Scientific is developing several additional indications for Precision, including migraine headache (1"The Gray Sheet" Feb. 7, 2005, p. 4)...
You may also be interested in...
Boston Scientific's Advanced Bionics unit expects to have a 100-person sales force in place by the end of the third quarter to market its Precision spinal cord stimulation (SCS) system for chronic pain and future indications, including migraine headache
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.